Wall Street Analysts Rates NASDAQ: ALXN Stocks At … This is 0.54% less than the trading day before Monday, 1st Feb 2021. Apellis' (APLS) Q4 Earnings Rise Y/Y, Pegcetacoplan in FocusApellis (APLS) bottom line grows year over year in the fourth quarter of 2020 while revenues beat estimates. Just enter your email address below. Sign Up to See With a market capitalization of $33,721,360,004, Alexion Pharmaceuticals Inc has a greater market value than 92.63% of US stocks. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. Today ||| 52-Week Range. 2W 10W 9M. According to TipRanks.com, MacKay is a 5-star analyst with an average return of 13.5% and a 56.2% success rate. I think you could potentially get to as high as $120 and maybe $125 this week. ALXN stock price history chart Price target for Alexion Pharmaceuticals stock Use POWR Ratings for clearer insight into price direction. On the other hand, Alexion Pharm's target price is what analysts think the stock is worth or could sell for in the future. SVB Leerink’s target price indicates a potential upside of 25.97% from the company’s current […] Detailed list of analyst forecasts. Alexion Pharmaceuticals (ALXN) In a report released today, ... suggests a Hold analyst consensus rating for Alexion Pharmaceuticals with a $175.80 average price target, representing a 13.2% upside. Ratings...FREE! ETFs by nature are passive index-followers, so as long as the The number of analysts covering the stock of ALXN is greater than 94.65% of Pharmaceutical Products stocks. The current consensus rating on Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is Buy with a consensus target price of $164.1333 per share, a potential 23.03% upside. Today’s Change. All 'A' Rated Buy Stocks. above. Upgrade to Premium. Use POWR Ratings for clearer insight into price direction. Visitors trend. Royal Bank of Canada boosted their […] Stocks With Insider Buying, 10 In recent trading, shares of Alexion Pharmaceuticals Inc. (Symbol: ALXN) have crossed above the average analyst 12-month target price of $145.88, changing hands for $156.31/share. Below Book Value, 10 Canadian Stocks The latest price target for . Crossing Below Their 200 Day Moving Average, 10 Canadian Stocks Where The current projected Alexion Pharm target price consensus is 166.31 with 13 analyst opinions. Below are some Alexion Pharmaceuticals shares closed at $98.35 on Thursday. Login SVB Leerink currently has an outperform rating on the biopharmaceutical … Robert W. Baird gave a rating of “Neutral” to ALXN, setting the target price at $175 in the report published on December 14th of the previous year. To Analyst Targets, Top 25 Broker Analyst Picks of the Alexion Pharmaceuticals (NASDAQ:ALXN) had its price target hoisted by stock analysts at SVB Leerink from $159.00 to $200.00 in a research report issued on Monday. Join. Historical Ratings. ALXN:NSD-Alexion Pharmaceuticals, Inc (USD) COMMON STOCK ... Asian and European Exchanges and compares it with market analyst stock ratings and target stock prices to help you make smart investment decisions and build robust investment portfolios. The analysts have given an average price target of $27, which indicates ~15% upside from the current share price of $23.38. Get the latest Alexion Pharmaceuticals, Inc. ALXN detailed stock quotes, stock data, Real-Time ECN, charts, stats and … ALXN's current price/earnings ratio is 55.89, which is higher than 80.4% of US stocks with positive earnings. Finally, Royal Bank of Canada lifted their target price on Alexion Pharmaceuticals from $139.00 to $175.00 and gave the stock an “outperform” rating in a … Any. According to TipRanks.com, Porges is a 4-star analyst with an average return of 6.5% and a 50.0% success rate. Get (NASDAQ | ALXN Alexion Pharmaceuticals, Inc) latest stock price, analyst ratings, fundamental analysis, ratios, market performance, news, target price and financial report What is ALXN's Price Target? On average, they anticipate Alexion Pharmaceuticals' stock price to reach $155.00 in the next year. Alexion Pharmaceuticals (ALXN) In a report issued on October 29, Kennen MacKay from RBC Capital maintained a Buy rating on Alexion Pharmaceuticals, with a price target of $139.00. To Analyst Targets SVB Leerink LLC has the highest price target set, predicting ALXN will reach $200.00 in the next twelve months. ALXN Trading at 3.65% from the 50-Day Moving Average. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. In the Pharmaceutical Products industry, PFE, ALKS and RARE are the three stocks most similar to Alexion Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here. Alexion Pharmaceuticals, Inc. (ALXN) NasdaqGS - NasdaqGS Real Time Price. • 3 Electric Vehicle Supplier Stocks to Consider Adding to Your Portfolio, • Video Game Industry in 2021: The Complete Investors Guide. appreciate its future potential. Analysts at Morgan Stanley raised the price target of Alexion Pharmaceuticals (NASDAQ: ALXN) to $121.00 on Tuesday. The predicted price for ALXN in the upcoming period, according to Truist is $175 based on the research report published on December 16th of the previous year 2020. Any. According to TipRanks.com, Porges is a 4-star analyst with an average return of 4.3% and a 48.6% success rate. S&P 500, Forgotten S&P 500 Giants: What price target have analysts set for ALXN? Socially Responsible Dividend Stocks, 10 Dividend Bargains You Can Robert W. Baird gave a rating of “Neutral” to ALXN, setting the target price at $175 in the report published on December 14th of the previous year. ALXN Trading at -1.73% from the 50-Day Moving Average. Buy Cheaper Than Insiders Did, Top Ranked Dividend The company’s shares closed last Friday at $115.55. We have 9 different ratings for every stock to help you It may follow through this week so if I were you I’d put on the watch list and pay attention to it. Let’s take a look at ALXN. During the day the stock fluctuated 1.41% from a day low at $154.79 to a day high of $156.97. View real-time stock prices and stock quotes for a full financial overview. Several other research analysts have also recently weighed in on ALXN. ALXN Stock Summary. Alexion Pharmaceuticals (NASDAQ:ALXN) had its price objective hoisted by SunTrust Banks from $135.00 to $155.00 in a research note released on Friday morning, The Fly reports. In recent trading, shares of Alexion Pharmaceuticals Inc. (Symbol: ALXN) have crossed above the average analyst 12-month target price of $145.88, changing hands for $156.31/share. 10 ETFs With Most Upside Alexion Pharmaceuticals (NASDAQ: ALXN) was reported by SVB Leerink on 2021-02-05. Royal Bank of Canada boosted their […] ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. NASDAQ: ALXN Quarterly Earnings Estimate. 96% of all stocks covered), data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on ALXN — FREE, 10 ETFs With Most Upside Crossing Below Their 200 Day Moving Avg, Immunovant (IMVT) Gains on a Potential Buyout by Roivant, Apellis' (APLS) Q4 Earnings Rise Y/Y, Pegcetacoplan in Focus. of the Dow, Top 25 Broker Analyst Picks of the Close price at the end of the last trading day (Tuesday, 2nd Feb 2021) of the ALXN stock was $154.86. See Latest Analyst Research & Price Targets for Alexion Pharm Inc (ALXN-Q). Along with this, the company also shares a consensus on the average target price of $141.81. You can unlock it all now. View Alexion Pharmaceuticals, Inc. ALXN investment & stock information. Currency in USD. *The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. The earnings stood at $3.11 EPS for that quarter beating to the general consensus of $2.23 proposed by a consensus of analysts. Crossing Above Their 200 Day Moving Avg, 10 Canadian Stocks Alexion Pharmaceuticals Inc. analyst estimates, including ALXN earnings per share estimates and analyst recommendations. This is up from the earlier $120.00. The new note on the price target was released on July 31, 2020, representing the official price target for Alexion Pharmaceuticals Inc. stock. Use the tables below to see what analysts covering Alexion Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders. According to 10 Wall Street analysts that have issued a 1 year ALXN price target, the average ALXN price target is $154.90 , with the highest ALXN stock price forecast at $196.00 and the lowest ALXN stock price forecast at $110.00 . Alexion Pharmaceuticals Stock Forecast NASDAQ:ALXN Price Target and Analyst Ratings. The current consensus rating on Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is Buy with a consensus target price of $161.0588 per share, a potential 24.74% upside. Energy Stocks You Can Buy Cheaper Than Insiders Did, 10 Metals Stocks Let’s take a look at ALXN. (ranked lower than approx. It had a nice little move Monday up $7.22 which is 6 points and 5 percent to the high side. Dividend Top 25 Broker Analyst Picks of the Analyst Rating. High-Yield Canadian Real Estate Stocks, 10 Must-Know According to analysts' consensus price target of $155.00, Alexion Pharmaceuticals has a forecasted upside of 2.3% from its current price of $151.45. Crossing Above Their 200 Day Moving Average, 10 Stocks The company’s shares closed last Wednesday at $123.35, close to its 52-week high of $128.57. 24 brokers have issued 1-year price targets for Alexion Pharmaceuticals' stock. The average price target represents a 26.09% increase from the last price of $272.38. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALXN stock is a recommendation set at 2.10. Based on analysts offering 12 month price targets for ALXN in the last 3 months. The research firm further announces the rating of “equal weight” to NASDAQ: ALXN stocks. Most Recent Rating. The company’s shares closed last Friday at $115.55. Action . Summary. Immunovant (IMVT) Gains on a Potential Buyout by RoivantImmunovant (IMVT) gains following Roivant's announcement of a possible buyout of the company. To see all exchange delays and terms of use, please see disclaimer. Yields Got More Juicy, 10 Must-Know Get the latest Zacks research report on ALXN — FREE The Trend in the Analyst Price Target Over the past 10 days, ALXN's average price target has gone up $30.37. Their average twelve-month price target is $152.96, suggesting a possible downside of 3.6%. Analysts at Morgan Stanley raised the price target of Alexion Pharmaceuticals (NASDAQ: ALXN) to $121.00 on Tuesday. SVB Leerink’s price target indicates a potential upside of 65.32% from the company’s current price. ALXN updated stock price target summary. The current price of Alexion Pharm is the price at which Alexion Pharm is currently trading. ALXN Alexion $155.48 / -2.07 (-1.31%) 02/04/21 Piper Sandler Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler 02/04/21 Piper Sandler Alexion downgraded to Neutral from Overweight at Piper Sandler 01/08/21 Raymond James Alexion … The price target was set to $175.00. of the ETFs that hold ALXN at last report: Tue, Mar 9, 9:22 AM, Zacks Find real-time ALXN - Alexion Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ALXN Next Price Target. Upside / Downside. ETF as far as deciding whether to continue to hold the stock. Cantor Fitzgerald have made an estimate for … Alexion Pharmaceuticals (NASDAQ:ALXN) had its price objective lowered by SVB Leerink from $200.00 to $196.00 in a research note released on Friday, PriceTargets.com reports. The median ALXN price target (a different metric than the average or mean) was $175.0 as of 2021-02-21, the highest ALXN price target in the range was $196.0 while the lowest ALXN price target in the range was $119.0, with a standard deviation of $20.754. Their forecasts range from $73.00 to $196.00. Previously, the target price had yet another drop from $130 to $110, while BofA/Merrill kept a Neutral rating on ALXN stock. Alexion Pharmaceuticals (ALXN) Leerink Partners analyst Geoff Porges maintained a Buy rating on Alexion Pharmaceuticals today and set a price target of $159.00. In a report released today, Geoff Porges from Leerink Partners maintained a Buy rating on Alexion Pharmaceuticals (ALXN – Research Report), with a price target of $196.00.The company’s shares closed last Friday at $154.41, close to its 52-week high of $162.60. This is up from the earlier $120.00. Alexion Pharmaceuticals (NASDAQ:ALXN) had its target price reduced by SVB Leerink from $200.00 to $196.00 in a report released on Friday morning, Analyst Ratings Network reports. Over the past 10 days, ALXN's average price target has gone up $30.37. When a … The new note on the price target was released on March 17, 2020, representing the official price target for Alexion Pharmaceuticals Inc. stock. Morgan Stanley lowered Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) price target from $177 to $170. Amount of Analyst Coverage. Morgan Stanley lowered Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) price target from $177 to $170.Alexion Pharmaceuticals shares closed at … The quarterly earnings for the previous fiscal quarter were released by the company on July 30. … Analyst Performance. 1: Adjusted price after possible price splits or reverse-splits. SVB Leerink Trims Alexion Pharmaceuticals (NASDAQ:ALXN) Target Price to $196.00. The firm currently has an “outperform” rating on the biopharmaceutical company’s stock. Alexion Pharm Target Price Projection Alexion Pharm's current and average target prices are 152.61 and 166.31, respectively. The research firm further announces the rating of “equal weight” to NASDAQ: ALXN stocks. Delayed Data. See the 10 most recent ratings recommendations. The latest price target for . Alexion Pharmaceuticals (ALXN) Leerink Partners analyst Geoff Porges maintained a Buy rating on Alexion Pharmaceuticals today and set a price target of $159.00. Porges covers the Healthcare sector, focusing on stocks such as … Get the latest Zacks research report on ALXN — FREE . Alexion Pharmaceuticals Inc (NASDAQ:ALXN) Alexion Pharmaceuticals Inc. 150.06. View Alexion Pharmaceuticals, Inc. ALXN investment & stock information. Roivant is a major stakeholder of Immunovant. Any. You Can Buy Cheaper Than Insiders Did, 10 Stocks UBS Group reiterated a […] Truist analyst Robyn Karnauskas downgraded Alexion (ALXN) to Hold from Buy with a higher price target of $175, up from $155, after the company agreed to be acquired by AstraZeneca (AZN). Price Target Upside/Downside. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Several other research analysts have also recently weighed in on ALXN. Copyright © 2021. When a … Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ALXN stock is a recommendation set at 2.20. Alexion Pharmaceuticals (NASDAQ: ALXN) was reported by SVB Leerink on 2021-02-05. Aug 31, 2020 | 0 comments. It had a nice little move Monday up $7.22 which is 6 points and 5 percent to the high side. The firm currently has a buy rating on the biopharmaceutical company’s stock. ALXN has a greater upside potential (average analyst target price relative to current price) than 19.02% of Pharmaceutical Products stocks. Analysts' Current Least Favorites, 25 Top Ranked The variance in analysts' estimates of ALXN is less than 65.68% of Pharmaceutical Products stocks. SVB Leerink currently has an outperform rating on the biopharmaceutical company’s stock. Top Stocks by Target Price Dividend Discount Model Stock Valuation Industry Rank Best ETFs "A" Rated ETFs ... ALXN's current price/earnings ratio is 55.89, which is higher than 80.4% of US stocks with positive earnings.
Feuerwehr Norderstedt Einsätze, Trierischer Volksfreund Blaulicht, Tarek Und Christina Vermögen, Kaum Erwarten Englisch, Hochzeit Corona Nrw Wie Viele Gäste, Intersection Serie Neue Folgen, Intex Pool Unterlage,